Advanced Biomed Inc. — Form 8-K
Filed November 20, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 4/100
What the filing says
Advanced Biomed Inc. (Nevada corp, Taiwan operations) agreed to sell up to 320,000 shares of common stock at $0.35/share ($112,000 total) to unnamed accredited/non-U.S. investors under Reg D/Reg S exemption. Agreement dated November 20, 2026; closing within 2 business days. Company has 1,652,133 shares outstanding pre-placement; 400M authorized. No counterparty names, amounts per investor, or final closing details disclosed in this form.
Why this rating
Capital raise of ~$112K is 4.1% of company's $2.7M market value—modest for a micro-cap. Standard private placement with no unique terms or conditions disclosed. Routine financing activity for small public company.
See more from November 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.